BlackRock’s Amgen AMGN Stock Holding History

BlackRock’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.6B	Sell	47,100,472 -295,666	-0.6%	-$105M	0.29%	55
2025 Q4	$15.5B	Buy	47,396,138 +1,361,706	+3%	+$432M	0.26%	60
2025 Q3	$13B	Sell	46,034,432 -563,906	-1%	-$164M	0.23%	71
2025 Q2	$13B	Buy	46,598,338 +1,158,907	+3%	+$328M	0.25%	65
2025 Q1	$14.2B	Sell	45,439,431 -206,717	-0.5%	-$61M	0.3%	54
2024 Q4	$11.9B	Sell	45,646,148 -599,823	-1%	-$178M	0.24%	65
2024 Q3	$14.9B	Buy	46,245,971 +203,242	+0.4%	+$66.5M	0.31%	48
2024 Q2	$14.4B	Sell	46,042,729 -1,928,344	-4%	-$567M	0.33%	45
2024 Q1	$13.6B	Buy	47,971,073 +158,683	+0.3%	+$46.4M	0.32%	50
2023 Q4	$13.8B	Buy	47,812,390 +237,506	+0.5%	+$64.7M	0.35%	42
2023 Q3	$12.8B	Buy	47,574,884 +620,831	+1%	+$155M	0.37%	40
2023 Q2	$10.4B	Sell	46,954,053 -1,826,180	-4%	-$424M	0.29%	53
2023 Q1	$11.8B	Buy	48,780,233 +265,593	+0.5%	+$65.2M	0.35%	46
2022 Q4	$12.7B	Buy	48,514,640 +1,643,932	+4%	+$441M	0.4%	38
2022 Q3	$10.6B	Buy	46,870,708 +45,156	+0.1%	+$10.9M	0.36%	43
2022 Q2	$11.4B	Sell	46,825,552 -3,202,618	-6%	-$785M	0.37%	44
2022 Q1	$12.1B	Sell	50,028,170 -18,175	-0%	-$4.18M	0.33%	52
2021 Q4	$11.3B	Buy	50,046,345 +1,032,929	+2%	+$218M	0.29%	57
2021 Q3	$10.4B	Buy	49,013,416 +1,188,514	+2%	+$274M	0.29%	56
2021 Q2	$11.7B	Sell	47,824,902 -947,172	-2%	-$233M	0.32%	52
2021 Q1	$12.1B	Buy	48,772,074 +966,280	+2%	+$231M	0.36%	45
2020 Q4	$11B	Sell	47,805,794 -179,634	-0.4%	-$41.4M	0.35%	48
2020 Q3	$12.2B	Sell	47,985,428 -744,156	-2%	-$184M	0.45%	36
2020 Q2	$11.5B	Buy	48,729,584 +2,267,217	+5%	+$517M	0.46%	37
2020 Q1	$9.42B	Buy	46,462,367 +205,870	+0.4%	+$45M	0.46%	38
2019 Q4	$11.2B	Buy	46,256,497 +241,107	+0.5%	+$53.1M	0.43%	35
2019 Q3	$8.9B	Sell	46,015,390 -1,701,926	-4%	-$327M	0.37%	41
2019 Q2	$8.79B	Buy	47,717,316 +1,585,911	+3%	+$284M	0.38%	41
2019 Q1	$8.76B	Buy	46,131,405 +4,009	+0%	+$766K	0.39%	38
2018 Q4	$8.98B	Buy	46,127,396 +906,568	+2%	+$177M	0.45%	34
2018 Q3	$9.37B	Sell	45,220,828 -565,010	-1%	-$111M	0.41%	38
2018 Q2	$8.45B	Sell	45,785,838 -1,076,122	-2%	-$190M	0.39%	38
2018 Q1	$7.99B	Sell	46,861,960 -2,563,314	-5%	-$471M	0.38%	42
2017 Q4	$8.6B	Sell	49,425,274 -368,980	-0.7%	-$65.3M	0.41%	43
2017 Q3	$9.28B	Buy	49,794,254 +343,051	+0.7%	+$60.8M	0.47%	35
2017 Q2	$8.52B	Buy	49,451,203 +909,689	+2%	+$148M	0.45%	34
2017 Q1	$7.96B	Buy	48,541,514 +46,489,004	+2,265%	+$7.72B	0.44%	35
2016 Q4	$300M	Buy	2,052,510 +2,426	+0.1%	+$365K	0.42%	41
2016 Q3	$342M	Sell	2,050,084 -58,707	-3%	-$9.93M	0.49%	36
2016 Q2	$321M	Buy	2,108,791 +118,285	+6%	+$18.4M	0.48%	38
2016 Q1	$298M	Sell	1,990,506 -413,217	-17%	-$61.4M	0.48%	38
2015 Q4	$390M	Buy	2,403,723 +3,723	+0.2%	+$585K	0.57%	37
2015 Q3	$332M	Buy	2,400,000 +146,298	+6%	+$23.1M	0.52%	38
2015 Q2	$346M	Sell	2,253,702 -150,439	-6%	-$24.1M	0.51%	40
2015 Q1	$384M	Buy	2,404,141 +152,360	+7%	+$24M	0.53%	38
2014 Q4	$359M	Sell	2,251,781 -812,732	-27%	-$127M	0.51%	42
2014 Q3	$430M	Buy	3,064,513 +589,339	+24%	+$76.9M	0.63%	30
2014 Q2	$293M	Buy	2,475,174 +157,281	+7%	+$18.2M	0.44%	51
2014 Q1	$286M	Sell	2,317,893 -115,480	-5%	-$14M	0.46%	46
2013 Q4	$278M	Buy	2,433,373 +165,966	+7%	+$18.9M	0.45%	47
2013 Q3	$254M	Buy	2,267,407 +20,946	+0.9%	+$2.27M	0.48%	42
2013 Q2	$222M	Buy	+2,246,461	New	+$233M	0.44%	47

Other funds holding AMGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock's AMGN Position: Q1 2026 in Review

BlackRock reduced its Amgen (AMGN) stake by 0.62% in Q1 2026, selling an estimated $105M and leaving 47,100,472 shares worth $16.6B. The position accounts for 0.29% of the portfolio, ranked #55.

BlackRock first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

BlackRock held 47,100,472 shares of Amgen worth $16.6B as of Q1 2026.
BlackRock sold 295,666 Amgen shares in Q1 2026, an estimated $105M.
Amgen made up 0.29% of BlackRock's portfolio in Q1 2026, its #55 holding.
BlackRock first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.